BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kang LM, Yu DP, Zheng Y, Zhou YH. Primary squamous cell carcinoma of the liver: A case report. World J Clin Cases 2022; 10(19): 6744-6749 [PMID: 35979286 DOI: 10.12998/wjcc.v10.i19.6744]
URL: https://www.wjgnet.com/1007-9327/full/v10/i19/6744.htm
Number Citing Articles
1
Lin Zhao, Yan Zhou, Jianmin Ding, Zhengyi Qin, Hongyu Zhou, Xiang Jing. Primary hepatic squamous cell carcinoma: case report and systematic review of the literatureFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1229936
2
Jian Jiang, Guomin Dong, Suoni Li, Jiequn Ma, Jie Bai, Jinzi Hui, Hongbian Gao, Zheng Zhao. Immunotherapy for primary squamous cell carcinoma of the liver: A case reportOncology Letters 2025; 29(6): 1 doi: 10.3892/ol.2025.15025
3
Soo Ryang Kim, Soo Ki Kim, Hisato Kobayashi, Toyokazu Okuda, Yumi Fujii, Makiho Sakamoto, Yu-ichiro Koma, Osamu Nakashima, Motoko Sasaki, Akira Asai, Hiroki Nishikawa. Primary Hepatic Squamous Cell CarcinomaDiagnostics 2026; 16(1): 120 doi: 10.3390/diagnostics16010120
4
Ryogo Minami, Masamichi Kimura, Koji Nishikawa, Jun Imamura, Kiminori Kimura. Clinical Outcomes of Hepatic Squamous Cell Carcinoma With Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation: A Case ReportCureus 2025;  doi: 10.7759/cureus.78024